Aprea Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are A...
Leadership
Oren Gilad Ph.D.Founder
Co-Founder, CEO, President & Director
John P. Hamill CPA
Senior VP, CFO, Principal Accounting Officer & Secretary
Lars B. Abrahmsen Ph.D.
Senior VP & Chief Scientific Officer
Brian Wiley
Senior Vice President of Corporate Development & Strategy
